| Patents for C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649) |
|---|
| 06/14/2007 | WO2007065292A1 Optically pure diamides and the preparation and uses thereof |
| 06/13/2007 | EP1794129A2 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 05/29/2007 | CA2197673C Drugs to improve synaptic transmission |
| 05/24/2007 | US20070117976 Method of purifying macrolides |
| 05/23/2007 | CN1317282C Method for extracting protopine from decumbent corydalis tuber |
| 05/16/2007 | CN1962639A Lappaconitine hydrochoric acid, its production method and its uses in preparing analgetic |
| 05/10/2007 | WO2007053145A1 Haloperidol analogs |
| 05/08/2007 | US7214803 Amidation of an alpha-pyrrolidinonylalkanoate by reaction with ammonium hydroxide |
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins |
| 05/02/2007 | EP1778699A2 Targeting chelants and chelates |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1957009A N-acylurea compounds for preparing polyrethanes |
| 05/01/2007 | US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand |
| 04/26/2007 | WO2007047737A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | US20070093379 Metal catalysts (preferably manganese-containing catalysts) complexed with selected macropolycyclic rigid ligands, preferably cross-bridged macropolycyclic ligands; useful for oxidative synthetic chemistry processes, bleaching of pulp and paper products |
| 04/26/2007 | CA2625423A1 Cb-1 modulating compounds and their use |
| 04/24/2007 | US7208140 Trimeric macrocyclic substituted benzene derivatives |
| 04/10/2007 | US7202246 Spiro-rifamycin derivatives targeting RNA polymerase |
| 04/04/2007 | EP1768558A1 Lipohilic derivatives of chelate monoamides |
| 03/28/2007 | EP1765073A2 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
| 03/15/2007 | WO2005117588A3 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 03/14/2007 | CN1927841A Carbonyl additive derivative of geldanamycin benzoquinone, preparation method and use thereof |
| 03/14/2007 | CN1927840A Aromatic reductive derivative of geldanamycin benzoquinone, preparation method and use thereof |
| 03/13/2007 | US7189549 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthase and accessory proteins, and uses thereof |
| 03/08/2007 | WO2007026027A1 Novel ansamycin derivatives |
| 03/08/2007 | WO2006020779A3 Targeting chelants and chelates |
| 03/08/2007 | CA2620023A1 Novel ansamycin derivatives |
| 03/07/2007 | EP1760054A2 Process for producing cyclic compound |
| 02/15/2007 | US20070037852 Migrastatin analogs and uses thereof |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037784 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/07/2007 | EP1749038A1 N-acylurea compounds for preparing polyurethanes |
| 01/31/2007 | EP1747005A2 Geldanamycin compounds and method of use |
| 01/23/2007 | US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 01/18/2007 | WO2007009007A2 Methods of treatment using hydroquinone ansamycins |
| 01/18/2007 | CA2612506A1 Methods of treatment using hydroquinone ansamycins |
| 01/17/2007 | CN1898212A Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 01/16/2007 | US7163935 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 01/11/2007 | US20070007884 Fluorescent complex and lighting system using the same |
| 01/09/2007 | US7161000 Method for producing phenol condensate |
| 01/04/2007 | WO2007001049A1 Benzenoid ansamycin derivative |
| 01/04/2007 | CA2613632A1 Benzenoid ansamycin derivative |
| 01/03/2007 | EP1737825A1 Geldanamycin and derivatives inhibit cancer invasion and identify novel targets |
| 01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 12/21/2006 | WO2006134385A2 Anti-inflammatory agents |
| 12/21/2006 | WO2006134384A1 Anti-inflammatory agents |
| 12/21/2006 | US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | CA2612298A1 Anti-inflammatory agents |
| 12/21/2006 | CA2612217A1 Anti-inflammatory agents |
| 12/14/2006 | US20060281949 Method for production $g(a),$g(b)-unsaturated amide compounds |
| 12/13/2006 | EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use |
| 12/12/2006 | US7148214 Antihistaminic spiro compounds |
| 12/07/2006 | DE102005025625A1 New benzazecine derivatives are dopamine receptor antagonists useful to treat schizophrenia |
| 11/28/2006 | US7141560 For use as analgesic or sedative; treating sleep disorders |
| 11/28/2006 | CA2113603C Tricyclic condensed heterocyclic compounds, their production and use |
| 11/22/2006 | CN1865257A Cyclopropanated macrocyclic ketones and lactones |
| 11/15/2006 | EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3 |
| 11/15/2006 | CN1863778A Compounds and methods for treating dyslipidemia |
| 11/14/2006 | CA2128955C Tricyclic benzazepine vasopressin antagonists |
| 11/09/2006 | WO2006119032A1 Method of treating multiple myeloma using 17-aag or 17-ag or a prodrug of either in combination with a proteasome inhibitor |
| 11/09/2006 | CA2604424A1 Method of treating multiple myeloma using 17-aag or 17-ag or a prodrug of either in combination with a proteasome inhibitor |
| 11/08/2006 | EP1021190B1 Amid derivatives as growth hormone release promotors |
| 11/02/2006 | EP1716119A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 10/31/2006 | US7129346 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/24/2006 | US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers |
| 10/24/2006 | US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization |
| 10/17/2006 | US7122677 NK1 antagonists |
| 10/17/2006 | US7122662 Tricyclic compound having spiro union |
| 10/03/2006 | US7115651 Macrocycles and uses thereof |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/26/2006 | US7112581 For therapy of cancer and infectious disease |
| 09/21/2006 | WO2006098761A2 Hsp90 inhibitors, methods of making and uses therefor |
| 09/20/2006 | CN1835936A Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/14/2006 | US20060205705 18,21-didehydro-18,21-dideoxo-18,21-dihydroxy-geldanamycin derivatives as anticarcinogenic agent; with a metal chelating agent |
| 09/06/2006 | CN1827617A Antivirus use of 17-(tetrahydrofuryl-2'-yl) methyl amine-17-demethoxy geldanamycin |
| 08/30/2006 | CN1826314A Method for production of dollar g(a), dollar g(b)-unsaturated amide compounds |
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/23/2006 | CN1271057C Method for preparing 1-methyl-3-ethyl-3-(3-hydroxy phenyl)-hexa hydrogen-1 H azepin hydrochloride |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/16/2006 | CN1817866A Group of geldanamycin derivative with nucleoside base |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/08/2006 | US7087384 Rare earth metal cryptates which are not very sensitive to the fluorescence quenching |
| 07/27/2006 | US20060167244 Polymerisation inhibitor |
| 07/26/2006 | EP1682514A1 11- o-methylgeldanamycin compounds |
| 07/26/2006 | EP1373215B1 Geldanamycin derivatives useful for treating cancer |
| 07/25/2006 | US7081474 Drugs to improve synaptic transmission |
| 07/13/2006 | US20060155120 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 07/05/2006 | EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/05/2006 | CN1262542C Geldanamycin derivative and method of treating cancer same |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/28/2006 | EP1272653B1 Methods for ansamitocin production |
| 06/21/2006 | EP1670768A1 Compounds and methods for treating dyslipidemia |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/15/2006 | WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/13/2006 | US7060818 Synthesis of macrocyclic tetraamido compounds and new metal insertion process |